Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-09

Clinical Trial Update: Pleotropic Effect of New Oral Anticoagulants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examines the pleiotropic effects of new oral anticoagulants in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN